110 related articles for article (PubMed ID: 37060880)
1. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study.
Sanjinez C; Botteri E; Støer NC; Lukas Löfling L
Lung Cancer; 2023 May; 179():107187. PubMed ID: 37060880
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and lung cancer survival: a population-based study in Norway.
Brancher S; Støer NC; Weiderpass E; Damhuis RAM; Johannesen TB; Botteri E; Strand TE
Br J Cancer; 2021 Mar; 124(5):1018-1025. PubMed ID: 33262518
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.
Nazir J; Hakimi Z; Guelfucci F; Khemiri A; Fatoye F; Blázquez AMM; González MH
BMC Urol; 2018 Sep; 18(1):76. PubMed ID: 30180826
[TBL] [Abstract][Full Text] [Related]
5. No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.
Kao LT; Huang CY; Lin HC; Chu CM
J Clin Pharmacol; 2018 Jun; 58(6):727-732. PubMed ID: 29315618
[TBL] [Abstract][Full Text] [Related]
6. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
J Gen Intern Med; 2020 Jul; 35(7):2084-2093. PubMed ID: 32026255
[TBL] [Abstract][Full Text] [Related]
7. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
Int J Geriatr Psychiatry; 2021 May; 36(5):684-696. PubMed ID: 33169433
[TBL] [Abstract][Full Text] [Related]
8. Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice.
Chapple CR; Nazir J; Hakimi Z; Bowditch S; Fatoye F; Guelfucci F; Khemiri A; Siddiqui E; Wagg A
Eur Urol; 2017 Sep; 72(3):389-399. PubMed ID: 28196724
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017).
Musika W; Kamsa-Ard S; Jirapornkul C; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2501-2507. PubMed ID: 34452564
[TBL] [Abstract][Full Text] [Related]
10. Antimuscarinic Use in Females With Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A 3-Year Follow-up Study.
Chung SD; Weng SS; Huang CY; Lin HC; Kao LT
J Clin Pharmacol; 2017 Aug; 57(8):1064-1070. PubMed ID: 28378881
[TBL] [Abstract][Full Text] [Related]
11. Risk of delirium associated with antimuscarinics in older adults: A case-time-control study.
Nishtala PS; Chyou TY
Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):883-891. PubMed ID: 35587029
[TBL] [Abstract][Full Text] [Related]
12. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia.
Masurkar PP; Chatterjee S; Sherer JT; Aparasu RR
Drugs Aging; 2021 Jul; 38(7):593-602. PubMed ID: 34027602
[TBL] [Abstract][Full Text] [Related]
13. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers.
Moga DC; Carnahan RM; Lund BC; Pendergast JF; Wallace RB; Torner JC; Li Y; Chrischilles EA
J Am Med Dir Assoc; 2013 Oct; 14(10):749-60. PubMed ID: 23639715
[TBL] [Abstract][Full Text] [Related]
15. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
Curr Med Res Opin; 2021 Aug; 37(8):1303-1313. PubMed ID: 33890538
[TBL] [Abstract][Full Text] [Related]
16. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
17. The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study.
Chuang MC; Yang YH; Hsieh MJ; Lin YC; Yang TM; Chen PC; Hung MS
BMC Cancer; 2021 Nov; 21(1):1257. PubMed ID: 34809588
[TBL] [Abstract][Full Text] [Related]
18. [Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients].
Feng T; Li HM; Yuan P; Yu DK; Ma F; Tan WW; Du ZL; Yang J; Huang Y; Lin DX; Xu BH; Tan W
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):115-120. PubMed ID: 28219206
[No Abstract] [Full Text] [Related]
19. Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.
Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
[TBL] [Abstract][Full Text] [Related]
20. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.
Salazar MC; Rosen JE; Wang Z; Arnold BN; Thomas DC; Herbst RS; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
JAMA Oncol; 2017 May; 3(5):610-619. PubMed ID: 28056112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
